About Credence MedSystems
Credence MedSystems is a company based in Menlo Park (United States) founded in 2011 by Dan Thayer. Credence MedSystems has raised $112.61 million across 10 funding rounds from investors including Novartis, Molex and Gates Foundation. Credence MedSystems offers products and services including Companion Syringe System, Dual Chamber Syringe System, Micro-Dose Syringe System, and Credence Connect Auto-Sensing System. Credence MedSystems operates in a competitive market with competitors including Insulet, Lyra Therapeutics, TriSalus Life Sciences, Cellectar Biosciences and Sixfold Bioscience, among others.
- Headquarter Menlo Park, United States
- Founders Dan Thayer
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Credence Medsystems, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$112.61 M (USD)
in 10 rounds
-
Latest Funding Round
$12.67 M (USD), Series D
Dec 17, 2024
-
Investors
Novartis
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Credence MedSystems
Credence MedSystems offers a comprehensive portfolio of products and services, including Companion Syringe System, Dual Chamber Syringe System, Micro-Dose Syringe System, and Credence Connect Auto-Sensing System.
Syringe for safe dosing and usability in pharmaceutical applications.
Facilitates delivery of complex drug formulations with ease.
Enables precise injections for specialized medical needs.
Provides data capture for enhanced clinical trial monitoring.
People of Credence MedSystems
Unlock access to complete
Funding Insights of Credence MedSystems
Credence MedSystems has successfully raised a total of $112.61M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $12.67 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Credence MedSystems
Credence MedSystems has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Novartis, Molex and Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Communication equipment manufacturer
|
Locked | Locked | Locked | |
|
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
Locked | Locked | Locked | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked |
Investor details for Credence MedSystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Credence MedSystems
Investment portfolio details for Credence MedSystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Credence MedSystems
Detailed financials for Credence MedSystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Credence Medsystems Comparisons
Peer comparison for Credence MedSystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Credence MedSystems
Credence MedSystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insulet, Lyra Therapeutics, TriSalus Life Sciences, Cellectar Biosciences and Sixfold Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for ENT diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of drug delivery devices to treat cancers
|
|
| Locked | Locked | Locked |
Phospholipid drug conjugates for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Oligonucleotide delivery systems are developed for targeted gene therapy.
|
Detailed competitors of Credence MedSystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Credence Medsystems
Complete news archive for Credence MedSystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Credence MedSystems
Credence MedSystems was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Credence MedSystems is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Jeff Shanley is the current CEO of Credence MedSystems.
Credence MedSystems is a funded company, having raised a total of $112.61M across 10 funding rounds to date.
Credence Medsystems manufactures and sells drug delivery technologies and prefilled pharmaceuticals. Its product portfolio includes Companion staked needle syringe, companion Luer syringe, companion dual chamber reconstitution safety syringe systems.
Credence MedSystems's top competitors include Insulet, Lyra Therapeutics and Halozyme.
Credence MedSystems offers Companion Syringe System, Dual Chamber Syringe System, Micro-Dose Syringe System, and Credence Connect Auto-Sensing System.
Credence MedSystems has 3 investors. Key investors include Novartis, Molex, and Gates Foundation.